The Global Adhesion Barrier Market size is expected to reach $1.2 billion by 2030, rising at a market growth of 7.2% CAGR during the forecast period.
Gynecological treatments use gel and film forms, such as ectopic pregnancy, ovarian cystectomy, and endometriosis surgery. Therefore, the Gynecological Surgeries segment registered $108.8 million revenue in the market in 2022. Cameras and robot-assisted devices are expensive equipment required for minimally invasive operations. Customers in developing nations that are price-sensitive are anticipated to adopt these devices. Adopting adhesion barriers is expected to be positively impacted by the slow adoption of minimally invasive techniques in developing countries. Some of the factors impacting the market are increase in road accident surgeries, increasing incidence of chronic diseases, and the less substitute methods of treatment.
The UN General Assembly has set the ambitious aim of halving traffic-related fatalities and injuries by 2030, according to the World Health Organization. Injury-related mortality on the road is the primary cause of death for children and young adults aged 5 to 29. More than 1.3 million people are killed annually in motor vehicle accidents. Over fifty percent of all road traffic fatalities involve vulnerable road users, cyclists, pedestrians, and motorcyclists. Adhesion formation is a significant post-surgical complication that requires additional surgical procedures for affected patients. Moreover, Chronic diseases, including cancer, endometriosis, and inflammatory bowel disease, are progressively increasing. According to the WHO, endometriosis globally impacts 10% (or 190 million) of women and girls of reproductive age. It is a chronic disease characterized by severe, life-altering pain during menstruation, sexual intercourse, bowel movements, and/or urination, chronic pelvic pain, abdominal bloating, nausea, fatigue, occasionally melancholy, anxiety, and infertility. Laparoscopic surgery (using a small camera to visualize inside the body) permits doctors to keep small incisions. Consequently, the market will grow due to a rise in the number of surgeries performed globally increases will increase the significance of these products and increase in the incidence of these diseases.
However, there are several alternative treatment options for eliminating adhesions without adhesion barriers. Medication, exercise, physical therapy, lifestyle modifications, and soft tissue mobilization are alternatives to surgery. Medications are frequently the first treatment for acute pain and a component of the treatment for chronic pain. Additionally, the majority of adhesions have no symptoms and don't require any sort of therapy. Additional operations will only increase adhesions. Because of this, unless blockages continue to cause symptoms, the healthcare professionals try to avoid surgery. A portion of individuals, however, prefer alternatives to adhesion barriers because, in most instances, they do not cause any issues, and there are a variety of available alternatives. In light of this, the market may experience slow expansion.
Furthermore, due to the COVID-19 pandemic's widespread distribution, the world's healthcare systems were under pressure. The COVID-19 pandemic had a negative effect on the market. Numerous clinics and hospitals all around the world were reconfigured to boost hospital capacity for COVID-19 patients. Nonetheless, it caused supply chain disruptions and put enormous pressure on the healthcare sector to meet the rising demand for patients with coronavirus infections. This resulted in a significant reduction in the demand for adhesion barriers.
Application Area Outlook
Based on application area, the market is classified into gynecological surgeries, general/abdominal surgeries, orthopedic surgeries, cardiovascular surgeries, neurological surgeries, urological surgeries, reconstructive surgeries, and others. The cardiovascular surgeries segment procured a promising growth rate in the market in 2022. According to WHO, 17.9 million people die from cardiovascular diseases (CVDs), the leading cause of death globally. The primary factors driving growth in this segment are the increasing prevalence of heart-related disorders and the expanding use of adhesion barriers in cardiovascular surgery.
Formulation Outlook
Based on formulation, the market is fragmented into film formulations, gel formulations, and liquid formulations. In 2022, the film formulations segment dominated the market with maximum revenue share. The wide availability of film-form adhesion barriers and the strong evidence demonstrating their efficacy and safety are two factors that contribute to this segment's significant market share. Compared to gel- and liquid-form adhesion barriers, surgeons have adopted film-form adhesion barriers more frequently due to the convenience of their use.
Product Outlook
By product, the market is segmented into synthetic products and natural products. The cost-effectiveness of synthetic adhesion barriers is anticipated to boost segment sales. In addition, the segment's dominance is predominantly attributable to the commercial availability of synthetic adhesion barriers. Postoperative complications such as adhesions can prolong hospital stays, lead to the need for additional surgeries, and increase recovery times.
End User Outlook
By end user, the market is categorized into hospitals & clinics, ambulatory surgical centers, and others. In 2022, the hospitals and clinics segment led the market by generating the highest revenue share. After surgical procedures, adhesion barriers are frequently used to reduce the risk of adhesion formation. Usually, hospitals employ a diverse team of medical professionals, including surgeons, anesthesiologists, nurses, and support staff, specializing in different aspects of surgery and patient care.
Regional Outlook
Region-wise, the market is analyzed across North America, Europe, Asia Pacific and LAMEA. In 2022, the North America region led the market by generating the highest revenue share. The region's established healthcare infrastructure, expanding surgical procedures, and growing awareness of the effects of adhesions on health all support market expansion. Moreover, the region's key market participants and technological advances fuel the market's development. The rapid economic development of the US and Canada, along with the existence of a universal healthcare coverage policy, has increased the accessibility of citizens to various healthcare facilities.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Sanofi S.A., Becton Dickinson and Company, Baxter International, Inc. (Hill-Rom Holdings, Inc.), Johnson & Johnson, Anika Therapeutic, Inc., FzioMed, Inc., MAST Biosurgery USA, Inc. (MAST Biosurgery AG), Innocoll Biotherapeutics N.A. Inc., Luna Innovations, Incorporated and Integra LifeSciences Holdings Corporation
Scope of the Study
Market Segments covered in the Report:
By Application Area
- General/Abdominal Surgeries
- Orthopedic Surgeries
- Gynecological Surgeries
- Cardiovascular Surgeries
- Urological Surgeries
- Neurological Surgeries
- Reconstructive Surgeries
- Others
By Formulation
- Film Formulations
- Gel Formulations
- Liquid Formulations
By Product
- Synthetic Products
- Hyaluronic Acid
- Regenerated Cellulose
- Polyethylene Glycol
- Others
- Natural Products
By End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Sanofi S.A.
- Becton Dickinson and Company
- Baxter International, Inc. (Hill-Rom Holdings, Inc.)
- Johnson & Johnson
- Anika Therapeutic, Inc.
- FzioMed, Inc.
- MAST Biosurgery USA, Inc. (MAST Biosurgery AG)
- Innocoll Biotherapeutics N.A. Inc.
- Luna Innovations, Incorporated
- Integra LifeSciences Holdings Corporation
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Global Adhesion Barrier Market, by Application Area
- 1.4.2 Global Adhesion Barrier Market, by Formulation
- 1.4.3 Global Adhesion Barrier Market, by Product
- 1.4.4 Global Adhesion Barrier Market, by End User
- 1.4.5 Global Adhesion Barrier Market, by Geography
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.3 Porter's Five Forces Analysis
Chapter 4. Global Adhesion Barrier Market by Application Area
- 4.1 Global General/Abdominal Surgeries Market by Region
- 4.2 Global Orthopedic Surgeries Market by Region
- 4.3 Global Gynecological Surgeries Market by Region
- 4.4 Global Cardiovascular Surgeries Market by Region
- 4.5 Global Urological Surgeries Market by Region
- 4.6 Global Neurological Surgeries Market by Region
- 4.7 Global Reconstructive Surgeries Market by Region
- 4.8 Global Others Market by Region
Chapter 5. Global Adhesion Barrier Market by Formulation
- 5.1 Global Film Formulations Market by Region
- 5.2 Global Gel Formulations Market by Region
- 5.3 Global Liquid Formulations Market by Region
Chapter 6. Global Adhesion Barrier Market by Product
- 6.1 Global Synthetic Products Market by Region
- 6.2 Global Adhesion Barrier Market by Synthetic Products Type
- 6.2.1 Global Hyaluronic Acid Market by Region
- 6.2.2 Global Regenerated Cellulose Market by Region
- 6.2.3 Global Polyethylene Glycol Market by Region
- 6.2.4 Global Others Market by Region
- 6.3 Global Natural Products Market by Region
Chapter 7. Global Adhesion Barrier Market by End User
- 7.1 Global Hospitals & Clinics Market by Region
- 7.2 Global Ambulatory Surgical Centers Market by Region
- 7.3 Global Others Market by Region
Chapter 8. Global Adhesion Barrier Market by Region
- 8.1 North America Adhesion Barrier Market
- 8.1.1 North America Adhesion Barrier Market by Application Area
- 8.1.1.1 North America General/Abdominal Surgeries Market by Country
- 8.1.1.2 North America Orthopedic Surgeries Market by Country
- 8.1.1.3 North America Gynecological Surgeries Market by Country
- 8.1.1.4 North America Cardiovascular Surgeries Market by Country
- 8.1.1.5 North America Urological Surgeries Market by Country
- 8.1.1.6 North America Neurological Surgeries Market by Country
- 8.1.1.7 North America Reconstructive Surgeries Market by Country
- 8.1.1.8 North America Others Market by Country
- 8.1.2 North America Adhesion Barrier Market by Formulation
- 8.1.2.1 North America Film Formulations Market by Country
- 8.1.2.2 North America Gel Formulations Market by Country
- 8.1.2.3 North America Liquid Formulations Market by Country
- 8.1.3 North America Adhesion Barrier Market by Product
- 8.1.3.1 North America Synthetic Products Market by Country
- 8.1.3.2 North America Adhesion Barrier Market by Synthetic Products Type
- 8.1.3.2.1 North America Hyaluronic Acid Market by Country
- 8.1.3.2.2 North America Regenerated Cellulose Market by Country
- 8.1.3.2.3 North America Polyethylene Glycol Market by Country
- 8.1.3.2.4 North America Others Market by Country
- 8.1.3.3 North America Natural Products Market by Country
- 8.1.4 North America Adhesion Barrier Market by End User
- 8.1.4.1 North America Hospitals & Clinics Market by Country
- 8.1.4.2 North America Ambulatory Surgical Centers Market by Country
- 8.1.4.3 North America Others Market by Country
- 8.1.5 North America Adhesion Barrier Market by Country
- 8.1.5.1 US Adhesion Barrier Market
- 8.1.5.1.1 US Adhesion Barrier Market by Application Area
- 8.1.5.1.2 US Adhesion Barrier Market by Formulation
- 8.1.5.1.3 US Adhesion Barrier Market by Product
- 8.1.5.1.4 US Adhesion Barrier Market by End User
- 8.1.5.2 Canada Adhesion Barrier Market
- 8.1.5.2.1 Canada Adhesion Barrier Market by Application Area
- 8.1.5.2.2 Canada Adhesion Barrier Market by Formulation
- 8.1.5.2.3 Canada Adhesion Barrier Market by Product
- 8.1.5.2.4 Canada Adhesion Barrier Market by End User
- 8.1.5.3 Mexico Adhesion Barrier Market
- 8.1.5.3.1 Mexico Adhesion Barrier Market by Application Area
- 8.1.5.3.2 Mexico Adhesion Barrier Market by Formulation
- 8.1.5.3.3 Mexico Adhesion Barrier Market by Product
- 8.1.5.3.4 Mexico Adhesion Barrier Market by End User
- 8.1.5.4 Rest of North America Adhesion Barrier Market
- 8.1.5.4.1 Rest of North America Adhesion Barrier Market by Application Area
- 8.1.5.4.2 Rest of North America Adhesion Barrier Market by Formulation
- 8.1.5.4.3 Rest of North America Adhesion Barrier Market by Product
- 8.1.5.4.4 Rest of North America Adhesion Barrier Market by End User
- 8.2 Europe Adhesion Barrier Market
- 8.2.1 Europe Adhesion Barrier Market by Application Area
- 8.2.1.1 Europe General/Abdominal Surgeries Market by Country
- 8.2.1.2 Europe Orthopedic Surgeries Market by Country
- 8.2.1.3 Europe Gynecological Surgeries Market by Country
- 8.2.1.4 Europe Cardiovascular Surgeries Market by Country
- 8.2.1.5 Europe Urological Surgeries Market by Country
- 8.2.1.6 Europe Neurological Surgeries Market by Country
- 8.2.1.7 Europe Reconstructive Surgeries Market by Country
- 8.2.1.8 Europe Others Market by Country
- 8.2.2 Europe Adhesion Barrier Market by Formulation
- 8.2.2.1 Europe Film Formulations Market by Country
- 8.2.2.2 Europe Gel Formulations Market by Country
- 8.2.2.3 Europe Liquid Formulations Market by Country
- 8.2.3 Europe Adhesion Barrier Market by Product
- 8.2.3.1 Europe Synthetic Products Market by Country
- 8.2.3.2 Europe Adhesion Barrier Market by Synthetic Products Type
- 8.2.3.2.1 Europe Hyaluronic Acid Market by Country
- 8.2.3.2.2 Europe Regenerated Cellulose Market by Country
- 8.2.3.2.3 Europe Polyethylene Glycol Market by Country
- 8.2.3.2.4 Europe Others Market by Country
- 8.2.3.3 Europe Natural Products Market by Country
- 8.2.4 Europe Adhesion Barrier Market by End User
- 8.2.4.1 Europe Hospitals & Clinics Market by Country
- 8.2.4.2 Europe Ambulatory Surgical Centers Market by Country
- 8.2.4.3 Europe Others Market by Country
- 8.2.5 Europe Adhesion Barrier Market by Country
- 8.2.5.1 Germany Adhesion Barrier Market
- 8.2.5.1.1 Germany Adhesion Barrier Market by Application Area
- 8.2.5.1.2 Germany Adhesion Barrier Market by Formulation
- 8.2.5.1.3 Germany Adhesion Barrier Market by Product
- 8.2.5.1.4 Germany Adhesion Barrier Market by End User
- 8.2.5.2 UK Adhesion Barrier Market
- 8.2.5.2.1 UK Adhesion Barrier Market by Application Area
- 8.2.5.2.2 UK Adhesion Barrier Market by Formulation
- 8.2.5.2.3 UK Adhesion Barrier Market by Product
- 8.2.5.2.4 UK Adhesion Barrier Market by End User
- 8.2.5.3 France Adhesion Barrier Market
- 8.2.5.3.1 France Adhesion Barrier Market by Application Area
- 8.2.5.3.2 France Adhesion Barrier Market by Formulation
- 8.2.5.3.3 France Adhesion Barrier Market by Product
- 8.2.5.3.4 France Adhesion Barrier Market by End User
- 8.2.5.4 Russia Adhesion Barrier Market
- 8.2.5.4.1 Russia Adhesion Barrier Market by Application Area
- 8.2.5.4.2 Russia Adhesion Barrier Market by Formulation
- 8.2.5.4.3 Russia Adhesion Barrier Market by Product
- 8.2.5.4.4 Russia Adhesion Barrier Market by End User
- 8.2.5.5 Spain Adhesion Barrier Market
- 8.2.5.5.1 Spain Adhesion Barrier Market by Application Area
- 8.2.5.5.2 Spain Adhesion Barrier Market by Formulation
- 8.2.5.5.3 Spain Adhesion Barrier Market by Product
- 8.2.5.5.4 Spain Adhesion Barrier Market by End User
- 8.2.5.6 Italy Adhesion Barrier Market
- 8.2.5.6.1 Italy Adhesion Barrier Market by Application Area
- 8.2.5.6.2 Italy Adhesion Barrier Market by Formulation
- 8.2.5.6.3 Italy Adhesion Barrier Market by Product
- 8.2.5.6.4 Italy Adhesion Barrier Market by End User
- 8.2.5.7 Rest of Europe Adhesion Barrier Market
- 8.2.5.7.1 Rest of Europe Adhesion Barrier Market by Application Area
- 8.2.5.7.2 Rest of Europe Adhesion Barrier Market by Formulation
- 8.2.5.7.3 Rest of Europe Adhesion Barrier Market by Product
- 8.2.5.7.4 Rest of Europe Adhesion Barrier Market by End User
- 8.3 Asia Pacific Adhesion Barrier Market
- 8.3.1 Asia Pacific Adhesion Barrier Market by Application Area
- 8.3.1.1 Asia Pacific General/Abdominal Surgeries Market by Country
- 8.3.1.2 Asia Pacific Orthopedic Surgeries Market by Country
- 8.3.1.3 Asia Pacific Gynecological Surgeries Market by Country
- 8.3.1.4 Asia Pacific Cardiovascular Surgeries Market by Country
- 8.3.1.5 Asia Pacific Urological Surgeries Market by Country
- 8.3.1.6 Asia Pacific Neurological Surgeries Market by Country
- 8.3.1.7 Asia Pacific Reconstructive Surgeries Market by Country
- 8.3.1.8 Asia Pacific Others Market by Country
- 8.3.2 Asia Pacific Adhesion Barrier Market by Formulation
- 8.3.2.1 Asia Pacific Film Formulations Market by Country
- 8.3.2.2 Asia Pacific Gel Formulations Market by Country
- 8.3.2.3 Asia Pacific Liquid Formulations Market by Country
- 8.3.3 Asia Pacific Adhesion Barrier Market by Product
- 8.3.3.1 Asia Pacific Synthetic Products Market by Country
- 8.3.3.2 Asia Pacific Adhesion Barrier Market by Synthetic Products Type
- 8.3.3.2.1 Asia Pacific Hyaluronic Acid Market by Country
- 8.3.3.2.2 Asia Pacific Regenerated Cellulose Market by Country
- 8.3.3.2.3 Asia Pacific Polyethylene Glycol Market by Country
- 8.3.3.2.4 Asia Pacific Others Market by Country
- 8.3.3.3 Asia Pacific Natural Products Market by Country
- 8.3.4 Asia Pacific Adhesion Barrier Market by End User
- 8.3.4.1 Asia Pacific Hospitals & Clinics Market by Country
- 8.3.4.2 Asia Pacific Ambulatory Surgical Centers Market by Country
- 8.3.4.3 Asia Pacific Others Market by Country
- 8.3.5 Asia Pacific Adhesion Barrier Market by Country
- 8.3.5.1 China Adhesion Barrier Market
- 8.3.5.1.1 China Adhesion Barrier Market by Application Area
- 8.3.5.1.2 China Adhesion Barrier Market by Formulation
- 8.3.5.1.3 China Adhesion Barrier Market by Product
- 8.3.5.1.4 China Adhesion Barrier Market by End User
- 8.3.5.2 Japan Adhesion Barrier Market
- 8.3.5.2.1 Japan Adhesion Barrier Market by Application Area
- 8.3.5.2.2 Japan Adhesion Barrier Market by Formulation
- 8.3.5.2.3 Japan Adhesion Barrier Market by Product
- 8.3.5.2.4 Japan Adhesion Barrier Market by End User
- 8.3.5.3 India Adhesion Barrier Market
- 8.3.5.3.1 India Adhesion Barrier Market by Application Area
- 8.3.5.3.2 India Adhesion Barrier Market by Formulation
- 8.3.5.3.3 India Adhesion Barrier Market by Product
- 8.3.5.3.4 India Adhesion Barrier Market by End User
- 8.3.5.4 South Korea Adhesion Barrier Market
- 8.3.5.4.1 South Korea Adhesion Barrier Market by Application Area
- 8.3.5.4.2 South Korea Adhesion Barrier Market by Formulation
- 8.3.5.4.3 South Korea Adhesion Barrier Market by Product
- 8.3.5.4.4 South Korea Adhesion Barrier Market by End User
- 8.3.5.5 Singapore Adhesion Barrier Market
- 8.3.5.5.1 Singapore Adhesion Barrier Market by Application Area
- 8.3.5.5.2 Singapore Adhesion Barrier Market by Formulation
- 8.3.5.5.3 Singapore Adhesion Barrier Market by Product
- 8.3.5.5.4 Singapore Adhesion Barrier Market by End User
- 8.3.5.6 Malaysia Adhesion Barrier Market
- 8.3.5.6.1 Malaysia Adhesion Barrier Market by Application Area
- 8.3.5.6.2 Malaysia Adhesion Barrier Market by Formulation
- 8.3.5.6.3 Malaysia Adhesion Barrier Market by Product
- 8.3.5.6.4 Malaysia Adhesion Barrier Market by End User
- 8.3.5.7 Rest of Asia Pacific Adhesion Barrier Market
- 8.3.5.7.1 Rest of Asia Pacific Adhesion Barrier Market by Application Area
- 8.3.5.7.2 Rest of Asia Pacific Adhesion Barrier Market by Formulation
- 8.3.5.7.3 Rest of Asia Pacific Adhesion Barrier Market by Product
- 8.3.5.7.4 Rest of Asia Pacific Adhesion Barrier Market by End User
- 8.4 LAMEA Adhesion Barrier Market
- 8.4.1 LAMEA Adhesion Barrier Market by Application Area
- 8.4.1.1 LAMEA General/Abdominal Surgeries Market by Country
- 8.4.1.2 LAMEA Orthopedic Surgeries Market by Country
- 8.4.1.3 LAMEA Gynecological Surgeries Market by Country
- 8.4.1.4 LAMEA Cardiovascular Surgeries Market by Country
- 8.4.1.5 LAMEA Urological Surgeries Market by Country
- 8.4.1.6 LAMEA Neurological Surgeries Market by Country
- 8.4.1.7 LAMEA Reconstructive Surgeries Market by Country
- 8.4.1.8 LAMEA Others Market by Country
- 8.4.2 LAMEA Adhesion Barrier Market by Formulation
- 8.4.2.1 LAMEA Film Formulations Market by Country
- 8.4.2.2 LAMEA Gel Formulations Market by Country
- 8.4.2.3 LAMEA Liquid Formulations Market by Country
- 8.4.3 LAMEA Adhesion Barrier Market by Product
- 8.4.3.1 LAMEA Synthetic Products Market by Country
- 8.4.3.2 LAMEA Adhesion Barrier Market by Synthetic Products Type
- 8.4.3.2.1 LAMEA Hyaluronic Acid Market by Country
- 8.4.3.2.2 LAMEA Regenerated Cellulose Market by Country
- 8.4.3.2.3 LAMEA Polyethylene Glycol Market by Country
- 8.4.3.2.4 LAMEA Others Market by Country
- 8.4.3.3 LAMEA Natural Products Market by Country
- 8.4.4 LAMEA Adhesion Barrier Market by End User
- 8.4.4.1 LAMEA Hospitals & Clinics Market by Country
- 8.4.4.2 LAMEA Ambulatory Surgical Centers Market by Country
- 8.4.4.3 LAMEA Others Market by Country
- 8.4.5 LAMEA Adhesion Barrier Market by Country
- 8.4.5.1 Brazil Adhesion Barrier Market
- 8.4.5.1.1 Brazil Adhesion Barrier Market by Application Area
- 8.4.5.1.2 Brazil Adhesion Barrier Market by Formulation
- 8.4.5.1.3 Brazil Adhesion Barrier Market by Product
- 8.4.5.1.4 Brazil Adhesion Barrier Market by End User
- 8.4.5.2 Argentina Adhesion Barrier Market
- 8.4.5.2.1 Argentina Adhesion Barrier Market by Application Area
- 8.4.5.2.2 Argentina Adhesion Barrier Market by Formulation
- 8.4.5.2.3 Argentina Adhesion Barrier Market by Product
- 8.4.5.2.4 Argentina Adhesion Barrier Market by End User
- 8.4.5.3 UAE Adhesion Barrier Market
- 8.4.5.3.1 UAE Adhesion Barrier Market by Application Area
- 8.4.5.3.2 UAE Adhesion Barrier Market by Formulation
- 8.4.5.3.3 UAE Adhesion Barrier Market by Product
- 8.4.5.3.4 UAE Adhesion Barrier Market by End User
- 8.4.5.4 Saudi Arabia Adhesion Barrier Market
- 8.4.5.4.1 Saudi Arabia Adhesion Barrier Market by Application Area
- 8.4.5.4.2 Saudi Arabia Adhesion Barrier Market by Formulation
- 8.4.5.4.3 Saudi Arabia Adhesion Barrier Market by Product
- 8.4.5.4.4 Saudi Arabia Adhesion Barrier Market by End User
- 8.4.5.5 South Africa Adhesion Barrier Market
- 8.4.5.5.1 South Africa Adhesion Barrier Market by Application Area
- 8.4.5.5.2 South Africa Adhesion Barrier Market by Formulation
- 8.4.5.5.3 South Africa Adhesion Barrier Market by Product
- 8.4.5.5.4 South Africa Adhesion Barrier Market by End User
- 8.4.5.6 Nigeria Adhesion Barrier Market
- 8.4.5.6.1 Nigeria Adhesion Barrier Market by Application Area
- 8.4.5.6.2 Nigeria Adhesion Barrier Market by Formulation
- 8.4.5.6.3 Nigeria Adhesion Barrier Market by Product
- 8.4.5.6.4 Nigeria Adhesion Barrier Market by End User
- 8.4.5.7 Rest of LAMEA Adhesion Barrier Market
- 8.4.5.7.1 Rest of LAMEA Adhesion Barrier Market by Application Area
- 8.4.5.7.2 Rest of LAMEA Adhesion Barrier Market by Formulation
- 8.4.5.7.3 Rest of LAMEA Adhesion Barrier Market by Product
- 8.4.5.7.4 Rest of LAMEA Adhesion Barrier Market by End User
Chapter 9. Company Profiles
- 9.1 Sanofi S.A.
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expense
- 9.1.5 SWOT Analysis
- 9.2 Becton, Dickinson, and Company
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 SWOT Analysis
- 9.3 Baxter International, Inc. (Hill-Rom Holdings, Inc.)
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental Analysis
- 9.3.4 Research & Development Expense
- 9.3.5 Recent strategies and developments:
- 9.3.5.1 Acquisition and Mergers:
- 9.3.6 SWOT Analysis
- 9.4 Johnson & Johnson
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental & Regional Analysis
- 9.4.4 Research & Development Expenses
- 9.4.5 SWOT Analysis
- 9.5 Anika Therapeutics, Inc.
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Regional Analysis
- 9.5.4 Research & Development Expenses
- 9.5.5 SWOT Analysis
- 9.6 FzioMed, Inc.
- 9.6.1 Company Overview
- 9.6.2 SWOT Analysis
- 9.7 MAST Biosurgery USA, Inc. (MAST Biosurgery AG)
- 9.7.1 Company Overview
- 9.7.2 SWOT Analysis
- 9.8 Innocoll Biotherapeutics N.A. Inc.
- 9.8.1 Company Overview
- 9.8.2 SWOT Analysis
- 9.9 Luna Innovations, Incorporated
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Regional Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 SWOT Analysis
- 9.10. Integra LifeSciences Holdings Corporation
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Segmental and Regional Analysis
- 9.10.4 Research & Development Expenses
- 9.10.5 SWOT Analysis
Chapter 10. Winning imperative for Adhesion Barrier Market